Determinants of population changes in fibrinogen and factor VII over 6 years - The atherosclerosis risk in communities (ARIC) study

被引:35
作者
Folsom, AR
Wu, KK
Rasmussen, M
Chambless, LE
Aleksic, N
Nieto, FJ
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA
[2] Univ Texas, Sch Med, Div Hematol, Houston, TX USA
[3] Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA
[4] Johns Hopkins Univ, Sch Hyg & Publ Hlth, Baltimore, MD USA
关键词
fibrinogen; factor VII; diabetes mellitus; studies; prospective;
D O I
10.1161/01.ATV.20.2.601
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although numerous cross-sectional studies have identified possible determinants of plasma fibrinogen and factor VII levels, few prospective studies exist. We assessed the longitudinal relation of changes in fibrinogen and factor vn over 6 years with changes to other cardiovascular risk factors in a sample of 440 men and 549 women from the Atherosclerosis Risk in Communities (ARIC) study. Fibrinogen increased more in older participants, those with or who developed diabetes, those who at any time smoked, and those whose plasma HDL cholesterol or triglycerides decreased and increased less in female participants who started hormonal replacement therapy. Factor VII coagulant activity increased more in younger participants, women, those who gained greater weight or developed diabetes, those who quit smoking, those in whom plasma triglycerides decreased, and female participants who received hormonal replacement therapy. Thus, our longitudinal data suggest with some exceptions that adverse changes in cardiovascular risk factors are accompanied by increases in plasma levels of fibrinogen and factor VII.
引用
收藏
页码:601 / 606
页数:6
相关论文
共 25 条
[1]  
BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936
[2]  
Chambless L E, 1992, Ann Epidemiol, V2, P723
[3]   METHODS FOR ASSESSING DIFFERENCE BETWEEN GROUPS IN CHANGE WHEN INITIAL MEASUREMENT IS SUBJECT TO INTRAINDIVIDUAL VARIATION [J].
CHAMBLESS, LE ;
ROEBACK, JR .
STATISTICS IN MEDICINE, 1993, 12 (13) :1213-1237
[4]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[5]   Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies [J].
Danesh, J ;
Collins, R ;
Appleby, P ;
Peto, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1477-1482
[6]   EPIDEMIOLOGY OF FIBRINOGEN [J].
FOLSOM, AR .
EUROPEAN HEART JOURNAL, 1995, 16 :21-24
[7]   Prospective study of hemostatic factors and incidence of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Wu, KK ;
Rosamond, WD ;
Sharrett, AR ;
Chambless, LE .
CIRCULATION, 1997, 96 (04) :1102-1108
[8]   POPULATION CORRELATES OF PLASMA-FIBRINOGEN AND FACTOR-VII, PUTATIVE CARDIOVASCULAR RISK-FACTORS [J].
FOLSOM, AR ;
WU, KK ;
DAVIS, CE ;
CONLAN, MG ;
SORLIE, PD ;
SZKLO, M .
ATHEROSCLEROSIS, 1991, 91 (03) :191-205
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]   FIBRINOGEN AND FACTOR-VII IN THE PREDICTION OF CORONARY RISK - RESULTS FROM THE PROCAM STUDY IN HEALTHY-MEN [J].
HEINRICH, J ;
BALLEISEN, L ;
SCHULTE, H ;
ASSMANN, G ;
VANDELOO, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (01) :54-59